Can a new infusion drug tame lung inflammation and cut steroid use?
Disease control
ENROLLING_BY_INVITATION
This trial is investigating whether an experimental drug called XTMAB-16 can safely control pulmonary sarcoidosis over the long term. The study includes people who have already completed a previous XTMAB-16 trial and are on a stable steroid dose. Researchers are monitoring side e…
Phase: PHASE2 • Sponsor: Xentria, Inc. • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC